Georges-Philippe Pageaux
Overview
Explore the profile of Georges-Philippe Pageaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
2849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nahon P, Lusivika-Nzinga C, Merle P, Zoulim F, Decaens T, Ganne-Carrie N, et al.
J Hepatol
. 2025 Feb;
PMID: 40020929
Background And Aims: The objective was to describe the dynamics of noninvasive tests (NITs) in cirrhotic patients following sustained virological response (SVR) and to assess their correlation with hepatocellular carcinoma...
2.
Nault J, Boubaya M, Wartski M, Dohan A, Pol S, Pop G, et al.
Lancet Gastroenterol Hepatol
. 2025 Feb;
10(4):306-314.
PMID: 39987937
Background: The role of PET-CT with [F]fluorodeoxyglucose ([F]FDG) and [F]fluorocholine ([F]FCH) in staging hepatocellular carcinoma and treatment decisions has, to our knowledge, never been prospectively assessed. Methods: We conducted a...
3.
Meszaros M, Hilleret M, Dumortier J, DAlteroche L, Abergel A, Latournerie M, et al.
Liver Int
. 2025 Feb;
45(3):e70033.
PMID: 39960163
Background And Aims: The impact of bulevirtide in patients awaiting liver transplantation (LT) for decompensated liver disease and/or hepatocellular carcinoma (HCC) is unclear. We assessed clinical, virological, and biochemical responses...
4.
Briant A, Morello R, Seree O, Vigneron N, Wilson S, Besch C, et al.
Clin Transplant
. 2025 Feb;
39(2):e70109.
PMID: 39945212
Background And Aim: De novo cancers after liver transplantation (LT) are major causes of complications and mortality after LT. No report was found in the literature on several successive cancers...
5.
Samuel D, De Martin E, Berg T, Berenguer M, Burra P, Fondevila C, et al.
J Hepatol
. 2024 Nov;
81(6):1040-1086.
PMID: 39487043
Liver transplantation (LT) is an established life-saving procedure. The field of LT has changed in the past 10 years from several perspectives, with the expansion of indications, transplantation of patients...
6.
Bargnoux A, Sutra T, Badiou S, Grillet P, Dupuy A, Szwarc I, et al.
Clin Chim Acta
. 2024 Oct;
565:120009.
PMID: 39426698
No abstract available.
7.
Hountondji L, Faure S, Palassin P, Viel P, Dupuy M, Larrey D, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(11-12):1561-1572.
PMID: 39315730
Background And Aims: While immune checkpoint inhibitors (ICIs) are revolutionising cancer therapy, checkpoint inhibitor-induced liver injury is a significant immune-related side effect of this immunotherapy. This study focuses on the...
8.
de Ledinghen V, Fougerou-Leurent C, Le Pabic E, Pol S, Alfaiate D, Lacombe K, et al.
JHEP Rep
. 2024 Jul;
6(8):101057.
PMID: 39045338
Background & Aims: In France, bulevirtide (BLV) became available in September 2019 through an early access program to treat patients with HDV. The aim of this analysis was to evaluate...
9.
Lam L, Soret P, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
22(12):2432-2441.e2.
PMID: 39019421
Background & Aims: In primary biliary cholangitis (PBC), static liver stiffness measurement (LSM) has proven prognostic value. However, the added prognostic value of LSM time course in this disease remains...
10.
Artru F, Sacleux S, Ursic-Bedoya J, Ntandja Wandji L, Lutu A, LHermite S, et al.
J Hepatol
. 2024 Jul;
82(1):62-71.
PMID: 38981560
Background & Aims: Utility, a major principle for allocation in the context of transplantation, is questioned in patients with acute-on-chronic liver failure grade 3 (ACLF-3) who undergo liver transplantation (LT)....